Use of tocilizumab in kidney transplant recipients with COVID-19

Acute respiratory distress syndrome associated with coronavirus infection is related to a cytokine storm with large interleukin-6 (IL-6) release. The IL-6-receptor blocker tocilizumab may control the aberrant host immune response in patients with coronavirus disease 2019 (COVID-19) . In this pandemi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Transplant
Main Authors: Pérez-Sáez, María J., Blasco, Miquel, Redondo-Pachón, Dolores, Ventura-Aguiar, Pedro, Bada-Bosch, Teresa, Pérez-Flores, Isabel, Melilli, Edoardo, Sánchez-Cámara, Luis A., López-Oliva, María O., Canal, Cristina, Shabaka, Amir, Garra-Moncau, Núria, Martín-Moreno, Paloma L., López, Verónica, Hernández-Gallego, Román, Siverio, Orlando, Galeano, Cristina, Espí-Reig, Jordi, Cabezas, Carlos J., Rodrigo, María T., Llinàs-Mallol, Laura, Fernández-Reyes, María J., Cruzado-Vega, Leónidas, Pérez-Tamajón, Lourdes, Santana-Estupiñán, Raquel, Ruiz-Fuentes, María C, Tabernero, Guadalupe, Zárraga, Sofía, Ruiz, Juan C, Gutiérrez-Dalmau, Alex, Mazuecos, Auxiliadora, Sánchez-Álvarez, Emilio, Crespo, Marta, Pascual, Julio
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. 2020
Assuntos:
Brief Communication
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7405397/
https://ncbi.nlm.nih.gov/pubmed/32654422
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ajt.16192
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados